Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
5QanxxX2NEhjKTFc
